Photodynamic therapy for cancer and activation of immune response

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 7565, Issue , 2010, Pages

  Mroz, Pawel ^a,b   Huang, Ying Ying ^a,b,c   Hamblin, Michael R ^a,b,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c GUANGXI MEDICAL UNIVERSITY   (China)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Anti tumor immunity; CpG oligonucleotides; Low dose cyclophosphamide; Photodynamic therapy; Regulatory T cells

Indexed keywords

ACTIVATED MACROPHAGES; ACUTE INFLAMMATORY RESPONSE; ANIMAL MODEL; ANTI-TUMOR IMMUNITY; ANTI-TUMORS; CYTOTOXIC; DANGER SIGNALS; DENDRITIC CELLS; ESCAPE MECHANISM; HEAT-SHOCK PROTEIN; IMMUNE RESPONSE; IMMUNOSTIMULATING; LOW DOSE; LOW DOSE CYCLOPHOSPHAMIDE; PATHOGENIC MICROORGANISMS; RECOGNITION SYSTEMS; T CELLS; TOLL-LIKE RECEPTORS;

ANTIGENS; DENDRIMERS; IMMUNOLOGY; MAMMALS; MICROORGANISMS; OLIGONUCLEOTIDES; OPTICAL MATERIALS; OPTIMIZATION; PATIENT MONITORING; PHOTODYNAMIC THERAPY; PLASMONS;

TUMORS;

EID: 77951553485     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.841031     Document Type: Conference Paper

References (56)

1. Castano, A. P., Demidova, T. N., and Hamblin, M. R., "Mechanisms in photodynamic therapy: part three - photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction," Photodiagn. Photodyn. Ther. 2, 91-106 (2005)
2. Castano, A. P., Mroz, P., and Hamblin, M. R., "Photodynamic therapy and anti-tumour immunity," Nat Rev Cancer. 6, 535-545 (2006)
3. Canti, G., Lattuada, D., Nicolin, A., Taroni, P., Valentini, G., and Cubeddu, R., "Antitumor immunity induced by photodynamic therapy with aluminum disulfonated phthalocyanines and laser light," Anti-Cancer Drugs. 5, 443-447 (1994) (Pubitemid 24237076)
4. Hendrzak-Henion, J. A., Knisely, T. L., Cincotta, L., Cincotta, E., and Cincotta, A. H., "Role of the immune system in mediating the antitumor effect of benzophenothiazine photodynamic therapy," Photochem. Photobiol. 69, 575-581 (1999) (Pubitemid 129555479)
5. Korbelik, M., and Dougherty, G. J., "Photodynamic therapy-mediated immune response against subcutaneous mouse tumors," Cancer Res. 59, 1941-1946 (1999)
6. Korbelik, M., Krosl, G., Krosl, J., and Dougherty, G. J., "The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy," Cancer Res. 56, 5647-5652 (1996) (Pubitemid 26422167)
7. Gollnick, S. O., Vaughan, L., and Henderson, B. W., "Generation of effective antitumor vaccines using photodynamic therapy," Cancer Res. 62, 1604-1608. (2002) (Pubitemid 34408477)
8. Gomer, C. J., Ryter, S. W., Ferrario, A., Rucker, N., Wong, S., and Fisher, A. M., "Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins," Cancer Res. 56, 2355-2360 (1996) (Pubitemid 26155168)
9. Mitra, S., Goren, E. M., Frelinger, J. G., and Foster, T. H., "Activation of heat shock protein 70 promoter with meso-tetrahydroxyphenyl chlorin photodynamic therapy reported by green fluorescent protein in vitro and in vivo," Photochem. Photobiol. 78, 615-622 (2003)
10. Korbelik, M., Sun, J., and Cecic, I., "Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response," Cancer Res. 65, 1018-1026 (2005) (Pubitemid 40216464)
11. Granville, D. J., Carthy, C. M., Jiang, H., Levy, J. G., McManus, B. M., Matroule, J. Y., Piette, J., and Hunt, D. W., "Nuclear factor-kappaB activation by the photochemotherapeutic agent verteporfin," Blood. 95, 256-262 (2000) (Pubitemid 30017250)
12. Kick, G., Messer, G., Plewig, G., Kind, P., and Goetz, A. E., "Strong and prolonged induction of c-jun and c-fos proto-oncogenes by photodynamic therapy," Br J Cancer. 74, 30-36 (1996) (Pubitemid 26231974)
13. Sun, J., Cecic, I., Parkins, C. S., and Korbelik, M., "Neutrophils as inflammatory and immune effectors in photodynamic therapy-treated mouse SCCVII tumours," Photochem. Photobiol. Sci. 1, 690-695 (2002) (Pubitemid 37069785)
14. de Vree, W. J., Essers, M. C., de Bruijn, H. S., Star, W. M., Koster, J. F., and Sluiter, W., "Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo," Cancer Res. 56, 2908-2911 (1996) (Pubitemid 26199729)
15. Krosl, G., Korbelik, M., and Dougherty, G. J., "Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy," Br. J. Cancer. 71, 549-555 (1995)
16. Cecic, I., Serrano, K., Gyongyossy-Issa, M., and Korbelik, M., "Characteristics of complement activation in mice bearing Lewis lung carcinomas treated by photodynamic therapy," Cancer Lett. 225, 215-223 (2005) (Pubitemid 40835869)
17. Adams, S., O'Neill, D. W., and Bhardwaj, N., "Recent advances in dendritic cell biology," J Clin Immunol. 25, 177-188 (2005)
18. O'Neill, D. W., Adams, S., and Bhardwaj, N., "Manipulating dendritic cell biology for the active immunotherapy of cancer," Blood. 104, 2235-2246 (2004) (Pubitemid 39331818)
19. Ferrantini, M., Capone, I., and Belardelli, F., "Dendritic cells and cytokines in immune rejection of cancer," Cytokine Growth Factor Rev. 19, 93-107 (2008) (Pubitemid 351200063)
20. Sparwasser, T., Vabulas, R. M., Villmow, B., Lipford, G. B., and Wagner, H., "Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T cell responses to soluble proteins," Eur J Immunol. 30, 3591-3597 (2000) (Pubitemid 32005232)
21. Mroz, P., Castano, A. P., and Hamblin, M. R. Stimulation of dendritic cells enhances immune response after photodynamic therapy. In: Biophotonics and Immune Responses IV, San Jose, CA, 2009, pp. doi: 10.1117/1112.809630.
22. Castano, A. P., and Hamblin, M. R. Enhancing photodynamic therapy of a metastatic mouse breast cancer by immune stimulation. In: Biophotonics and Immune Responses, San Jose, 2006, pp. 608703.
23. Clayton, L. K., Ghendler, Y., Mizoguchi, E., Patch, R. J., Ocain, T. D., Orth, K., Bhan, A. K., Dixit, V. M., and Reinherz, E. L., "T-cell receptor ligation by peptide/MHC induces activation of a caspase in immature thymocytes: the molecular basis of negative selection," Embo J. 16, 2282-2293 (1997) (Pubitemid 27258630)
24. Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., Zhu, Y., Wei, S., Kryczek, I., Daniel, B., Gordon, A., Myers, L., Lackner, A., Disis, M. L., Knutson, K. L., Chen, L., and Zou, W., "Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival," Nat Med. 10, 942-949 (2004) (Pubitemid 39273735)
25. Dejaco, C., Duftner, C., Grubeck-Loebenstein, B., and Schirmer, M., "Imbalance of regulatory T cells in human autoimmune diseases," Immunology. 117, 289-300 (2006)
26. Yamaguchi, T., and Sakaguchi, S., "Regulatory T cells in immune surveillance and treatment of cancer," Semin Cancer Biol. 16, 115-123 (2006) (Pubitemid 43172060)
27. Antony, P. A., and Restifo, N. P., "CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2," J Immunother. 28, 120-128 (2005)
28. Fontenot, J. D., and Rudensky, A. Y., "A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3," Nat Immunol. 6, 331-337 (2005)
29. Scotto, L., Naiyer, A. J., Galluzzo, S., Rossi, P., Manavalan, J. S., Kim-Schulze, S., Fang, J., Favera, R. D., Cortesini, R., and Suciu-Foca, N., "Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells," Hum Immunol. 65, 1297-1306 (2004)
30. Albers, A. E., Ferris, R. L., Kim, G. G., Chikamatsu, K., DeLeo, A. B., and Whiteside, T. L., "Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites," Cancer Immunol Immunother. 54, 1072-1081 (2005) (Pubitemid 41396812)
31. Ziegler, S. F., "FOXP3: of mice and men," Annu Rev Immunol. 24, 209-226 (2006)
32. Zou, W., "Regulatory T cells, tumour immunity and immunotherapy," Nat Rev Immunol. 6, 295-307 (2006)
33. Jones, E., Golgher, D., Simon, A. K., Dahm-Vicker, M., Screaton, G., Elliott, T., and Gallimore, A., "The influence of CD25+ cells on the generation of immunity to tumour cell lines in mice," Novartis Found Symp. 256, 149-152; discussion 152-147, 259-1169 (2004)
34. Curotto de Lafaille, M. A., Lino, A. C., Kutchukhidze, N., and Lafaille, J. J., "CD25- T cells generate CD25+Foxp3+ regulatory T cells by peripheral expansion," J Immunol. 173, 7259-7268 (2004) (Pubitemid 39628162)
35. Chen, W., Jin, W., Hardegen, N., Lei, K. J., Li, L., Marinos, N., McGrady, G., and Wahl, S. M., "Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3," J Exp Med. 198, 1875-1886 (2003)
36. Bluestone, J. A., and Tang, Q., "How do CD4+CD25+ regulatory T cells control autoimmunity?," Curr Opin Immunol. 17, 638-642 (2005) (Pubitemid 41506909)
37. Tang, Q., Boden, E. K., Henriksen, K. J., Bour-Jordan, H., Bi, M., and Bluestone, J. A., "Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T cell function," Eur J Immunol. 34, 2996-3005 (2004) (Pubitemid 39549379)
38. Stephens, G. L., McHugh, R. S., Whitters, M. J., Young, D. A., Luxenberg, D., Carreno, B. M., Collins, M., and Shevach, E. M., "Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells," J Immunol. 173, 5008-5020 (2004) (Pubitemid 39387783)
39. Marie, J. C., Letterio, J. J., Gavin, M., and Rudensky, A. Y., "TGF-beta1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells," J Exp Med. 201, 1061-1067 (2005) (Pubitemid 40524674)
40. Ghiringhelli, F., Puig, P. E., Roux, S., Parcellier, A., Schmitt, E., Solary, E., Kroemer, G., Martin, F., Chauffert, B., and Zitvogel, L., "Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation," J Exp Med. 202, 919-929 (2005) (Pubitemid 41396892)
41. Veldhoen, M., Moncrieffe, H., Hocking, R. J., Atkins, C. J., and Stockinger, B., "Modulation of dendritic cell function by naive and regulatory CD4+ T cells," J Immunol. 176, 6202-6210 (2006)
42. Rudensky, A. Y., and Campbell, D. J., "In vivo sites and cellular mechanisms of T reg cell-mediated suppression," J Exp Med. 203, 489-492 (2006)
43. Wang, H. Y., Lee, D. A., Peng, G., Guo, Z., Li, Y., Kiniwa, Y., Shevach, E. M., and Wang, R. F., "Tumor-specific human CD4+ regulatory T cells and their ligands: implications for immunotherapy," Immunity. 20, 107-118 (2004) (Pubitemid 38134298)
44. Onizuka, S., Tawara, I., Shimizu, J., Sakaguchi, S., Fujita, T., and Nakayama, E., "Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody," Cancer Res. 59, 3128-3133 (1999) (Pubitemid 29316012)
45. Antony, P. A., Piccirillo, C. A., Akpinarli, A., Finkelstein, S. E., Speiss, P. J., Surman, D. R., Palmer, D. C., Chan, C. C., Klebanoff, C. A., Overwijk, W. W., Rosenberg, S. A., and Restifo, N. P., "CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells," J Immunol. 174, 2591-2601 (2005) (Pubitemid 40279672)
46. Yu, P., Lee, Y., Liu, W., Krausz, T., Chong, A., Schreiber, H., and Fu, Y. X., "Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors," J Exp Med. 201, 779-791 (2005) (Pubitemid 40395122)
47. Rollinghoff, M., Starzinski-Powitz, A., Pfizenmaier, K., and Wagner, H., "Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes," J Exp Med. 145, 455-459 (1977) (Pubitemid 8032100)
48. Glaser, M., "Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice," J Exp Med. 149, 774-779 (1979) (Pubitemid 9137688)
49. Berendt, M. J., and North, R. J., "T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor," J. Exp. Med. 151, 69-80 (1980)
50. Ghiringhelli, F., Larmonier, N., Schmitt, E., Parcellier, A., Cathelin, D., Garrido, C., Chauffert, B., Solary, E., Bonnotte, B., and Martin, F., "CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative," Eur J Immunol. 34, 336-344 (2004) (Pubitemid 39255944)
51. Loeffler, M., Kruger, J. A., and Reisfeld, R. A., "Immunostimulatory effects of low-dose cyclophosphamide are controlled by inducible nitric oxide synthase," Cancer Res. 65, 5027-5030 (2005) (Pubitemid 40827309)
52. Lutsiak, M. E., Semnani, R. T., De Pascalis, R., Kashmiri, S. V., Schlom, J., and Sabzevari, H., "Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide," Blood. 105, 2862-2868 (2005) (Pubitemid 40446280)
53. Motoyoshi, Y., Kaminoda, K., Saitoh, O., Hamasaki, K., Nakao, K., Ishii, N., Nagayama, Y., and Eguchi, K., "Different mechanisms for anti-tumor effects of low- and high-dose cyclophosphamide," Oncol Rep. 16, 141-146 (2006)
54. Brode, S., Raine, T., Zaccone, P., and Cooke, A., "Cyclophosphamide- induced type-1 diabetes in the NOD mouse is associated with a reduction of CD4+CD25+Foxp3+ regulatory T cells," J Immunol. 177, 6603-6612 (2006) (Pubitemid 44715023)
55. Taieb, J., Chaput, N., Schartz, N., Roux, S., Novault, S., Menard, C., Ghiringhelli, F., Terme, M., Carpentier, A. F., Darrasse-Jeze, G., Lemonnier, F., and Zitvogel, L., "Chemoimmunotherapy of tumors: cyclophosphamide synergizes with exosome based vaccines," J Immunol. 176, 2722-2729 (2006) (Pubitemid 43306930)
56. Castano, A. P., Mroz, P., Wu, M. X., and Hamblin, M. R., "Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model," Proc Natl Acad Sci U S A. 105, 5495-5500 (2008) (Pubitemid 351753891)